Latest / Community Health Media
Dr. Mark Pegram & Dr. Carol Tweed - Is Cleopatra Finally Over? New First-Line Strategies in HER2+ Metastatic Breast Cancer
Recorded live around the latest data from SABCS, ASCO, and ESMO, this in-depth conversation features Dr. Mark Pegram and Dr. Carol Tweed examining whether the long-standing Cleopatra regimen is finally giving way to a new first-line standard in HER2-positive metastatic breast cancer.
From Destiny-Breast09 and unprecedented progression-free survival results to response depth, CNS considerations, and the real-world implications of continuous ADC therapy, this discussion breaks down what the data truly mean for patient care.
The conversation also explores induction vs. maintenance strategies…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.